Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
Millenium Health Gets Win on Appeal of POCT Cup Litigation; But What’s Next?
By Kelly A. Briganti, Editorial Director, G2 Intelligence It's been several years but Millenium won an appeal in a lawsuit Ameritox brought against the company arguing Millenium's point-of-care testing (POCT) cup program violated unfair competition laws and the...
LabCorp Releases Hereditary Cancer Test Panel
By Ron Shinkman, Editor, Laboratory Industry Report LabCorp has launched a prognostic panel intended to gauge the risk of patients being stricken by the most common forms of cancer. The panel, known as VistaSeq, will be used to identify patients at a higher risk of...
NIH Expands eMerge Initiative With $48M in Phase III Awards
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies The National Institutes of Health announced awards for $48 million in the third round of funding for the eMERGE program. The Electronic Medical Records and Genomics (eMERGE) project's primary goal...